Cardiometabolic prediction models for young people with psychosis spectrum disorders in the UK (PsyMetRiC 2.0): a retrospective, multicohort clinical prediction model study.

Abstract

Young people with psychosis spectrum disorders are at a high risk of cardiometabolic morbidity and subsequent premature mortality, but there are no accurate clinic-ready prediction models for this group. We aimed to collaboratively refine, extend, and validate the Psychosis Metabolic Risk Calculator (PsyMetRiC) prediction models for accuracy, clinical usefulness, and acceptability, and to translate the models into a regulated, clinically available medical device. In this retrospective, multicoho